Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus
Patent
1983-02-25
1985-03-05
Chan, Nicky
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Genetically modified micro-organism, cell, or virus
514 21, A61K 3512, A61K 3702
Patent
active
045030383
ABSTRACT:
A nonmitogenic angiogenesis factor is isolated from wound fluid by dialysis to include materials in the molecular size range of 2,000 to 14,000, lyophilization, and chromatography. The nonmitogenic angiogenesis factor is identified by activity by corneal implant assay and by cell migration assay. The angiogenesis factor is also characterized by inactivity by mitogenesis assay.
REFERENCES:
Banda, et al. including Oredsson, S., "Purification . . . from Rabbit Wound Fluid", Fed. Proc. 41(3), 1982, 1085.
Banda Michael J.
Hunt Thomas K.
Knighton David R.
Werb Zena
Chan Nicky
Stone Jacqueline M.
The Regents of the University of California
LandOfFree
Extracellular nonmitogenic angiogenesis factor and method of iso does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Extracellular nonmitogenic angiogenesis factor and method of iso, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Extracellular nonmitogenic angiogenesis factor and method of iso will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1734025